China Further Restricts Antibiotic Use, Expands Monitoring Networks To More Hospitals
This article was originally published in PharmAsia News
Executive Summary
As the world’s largest consumer of antibiotics, China will soon implement a new regulation that further restricts use, and expands monitoring of adverse events and drug resistance.
You may also be interested in...
Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?
SHANGHAI - China's State Council Aug. 4 released a formal draft of a new policy to address the abuse of anti-infectives and is soliciting public comments. Surprising analysts, the draft policy is less strict than a previous version that had circulated around industry, leaving the future of China's anti-infective market more difficult to predict
China To Issue Strict Limits On Antibiotic Usage By July; Large Sales Cuts Expected
SHANGHAI - China's Ministry Of Health is collecting public feedback on a draft version of guidance that will significantly restrict the use of anti-infectives, and is planning to implement a final version in July. The new policy could slow down the rapid growth of China's anti-infective market - the largest drug class in China - which saw a 24.5% compound annual growth rate during 2006-2009
Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields
SHANGHAI - While Beijing is hosting China's National People's Congress this week to discuss and design its next Five-Year Plan, China's powerful National Development and Reform Commission announced another round of price cuts on antibiotics and cardiovascular drugs with an average price reduction of 21%, less than the rumored 30-40% cuts, but still a blow to Big Pharma